Table 3 Antifungal activity (expressed by inhibitory zone) of different concentrations of ZnONPs in comparison with some commercially available antifungals (Nystatin and Voriconazole) against different Candida species
From: Isolation and identification of Candida spp. from immunocompromised patients
Candida spp. | Inhibition zone (mm) | |||||
|---|---|---|---|---|---|---|
Concentrations of (ZnONPs) µg/disc | Nystatin (100 unit/disc) | Voriconazole (1 µg/disc) | Negative control | |||
25 | 50 | 100 | ||||
C. albicans | 0 | 0 | 40 | 10 | 44 | 0 |
C. tropicalis | 0 | 0 | 9 | 11 | 22 | 0 |
C. glabrata | 0 | 0 | 26 | 20 | 52 | 0 |
C. krusei | 0 | 0 | 0 | 12 | 40 | 0 |
C. parapsilosis | 0 | 7 | 42 | 13 | 0 | 0 |